BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12912704)

  • 1. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM; Aouchiche R; Freedman KA
    Arch Ophthalmol; 2003 Aug; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract]   [Full Text] [Related]  

  • 2. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM
    Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
    Bacal DA; Levy SR
    Arch Ophthalmol; 2004 Feb; 122(2):276-9. PubMed ID: 14769608
    [No Abstract]   [Full Text] [Related]  

  • 4. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A; Borruat FX
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL; Hsiao CH; Chen JT; Lu DW; Chen WY
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using apraclonidine in diagnosing Horner syndrome in children.
    Sueke H; Chandna A
    Am J Ophthalmol; 2010 May; 149(5):869; author reply 870. PubMed ID: 20399934
    [No Abstract]   [Full Text] [Related]  

  • 7. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
    Lebas M; Seror J; Debroucker T
    J Neuroophthalmol; 2010 Mar; 30(1):12-7. PubMed ID: 20182200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
    Koc F; Kavuncu S; Kansu T; Acaroglu G; Firat E
    Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apraclonidine in the diagnosis of Horner's syndrome.
    Moodley AA; Spooner RB
    S Afr Med J; 2007 Jul; 97(7):506-7. PubMed ID: 17824139
    [No Abstract]   [Full Text] [Related]  

  • 10. Teaching NeuroImages: Positive apraclonidine test in Horner syndrome.
    Shin RK; Cheek AG
    Neurology; 2011 May; 76(20):e100. PubMed ID: 21576682
    [No Abstract]   [Full Text] [Related]  

  • 11. False-negative apraclonidine testing in acute Horner syndrome.
    Dewan MA; Harrison AR; Lee MS
    Can J Ophthalmol; 2009 Feb; 44(1):109-10. PubMed ID: 19169332
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC; Hindman HB; Grant MP; Iliff NT; Merbs SL
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):53-5. PubMed ID: 16418668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical apraclonidine to diagnose Bernard-Horner syndrome.
    Kocabora M; Gocmez E; Taskapili M
    Bull Soc Belge Ophtalmol; 2009; (312):9-15. PubMed ID: 19927485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P; Satterfield D; Lim MK
    J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation of Horner's syndrome using apraclonidine eye drops.
    Chu CJ; Ferris JD
    Postgrad Med J; 2011 Jun; 87(1028):440. PubMed ID: 21386103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA; González I; Fernández FJ; Díaz S; Ferrer C; Alias E; Honrubia FM
    Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible effect of systemic sympathicolytic drugs on apraclonidine test.
    Martín-Moro JG; Botín DM; Muñoz-Negrete FJ
    Can J Ophthalmol; 2009 Aug; 44(4):463; author reply 463-4. PubMed ID: 19606173
    [No Abstract]   [Full Text] [Related]  

  • 18. Early diagnosis of Horner syndrome using topical apraclonidine.
    Cooper-Knock J; Pepper I; Hodgson T; Sharrack B
    J Neuroophthalmol; 2011 Sep; 31(3):214-6. PubMed ID: 21566530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pupillary autonomic neuropathy simulating partial Horner syndrome in diabetes mellitus and its reversal with control of blood glucose.
    Pishdad GR; Pishdad P; Pishdad R
    J Neuroophthalmol; 2008 Sep; 28(3):241-2. PubMed ID: 18769297
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ; Yang HK; Hwang JM
    PLoS One; 2017; 12(6):e0178361. PubMed ID: 28575101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.